Abstract
Activation of substance P receptors, which are coupled to Gαq, inhibits the Kir3.1/3.2 channels, resulting in neuronal excitation. We have shown previously that this channel inactivation is not caused by reduction of the phosphatidylinositol 4,5-bisphosphate level in membrane. Moreover, Gαq immunoprecipitates with Kir3.2 (J Physiol564:489–500, 2005), suggesting that Gαq interacts with Kir3.2. Positive immunoprecipitation, however, does not necessarily indicate direct interaction between the two proteins. Here, the glutathione transferase pull-down assay was used to investigate interaction between Gαq and the K+ channels. We found that Gαq interacted with N termini of Kir3.1, Kir3.2, and Kir3.4. However, Gαq did not interact with the C terminus of any Kir3 or with the C or N terminus of Kir2.1. TRPC6 is regulated by the signal initiated by Gαq. Immunoprecipitation, however, showed that Gαq did not interact with TRPC6. Thus, the interaction between Gαq and the Kir3 N terminus is quite specific. This interaction occurred in the presence of GDP or GDP-AlF–4. The Gαq binding could take place somewhere between residues 51 to 90 of Kir3.2; perhaps the segment between 81 to 90 residues is crucial. Gβγ, which is known to bind to N terminus of Kir3, did not compete with Gαq for the binding, suggesting that these two binding regions are different. These findings agree with the hypothesis (J Physiol564:489–500, 2005) that the signal to inactivate the Kir3 channel could be mainly transmitted directly from Gαq to Kir3.
Footnotes
-
This work was supported by National Institutes of Health grants AG06093, GM59427, NS41441, GM61454, and T32-HL07692 T.Ko. and S.N. equally contributed to this article.
-
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
-
doi:10.1124/mol.106.032508.
-
ABBREVIATIONS: SP, substance P; GIRK, G protein-coupled inwardly rectifying K+ channels; GST, glutathione transferase; HEK, human embryonic kidney; PIP2, phosphatidylinositol 4,5-bisphosphate; RGS, regulator of G protein signaling; GRK2-RH, RGS homology domain of G protein-coupled receptor kinase 2.
-
↵1 Current affiliation: Department of Rehabilitation Medicine, Montefiore Medical Center, The University Hospital for the Albert Einstein College of Medicine, Bronx, New York.
- Received November 8, 2006.
- Accepted February 12, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|